These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14727978)

  • 21. Ramipril for the prevention and treatment of cardiovascular disease.
    Vuong AD; Annis LG
    Ann Pharmacother; 2003 Mar; 37(3):412-9. PubMed ID: 12639174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group.
    Lièvre M; Marre M; Chatellier G; Plouin P; Réglier J; Richardson L; Bugnard F; Vasmant D
    Control Clin Trials; 2000 Aug; 21(4):383-96. PubMed ID: 10913814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on ramipril in the prevention of cardiovascular outcomes.
    Warner GT; Perry CM
    Am J Cardiovasc Drugs; 2003; 3(2):113-6. PubMed ID: 14727938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibitors and survival of hemodialysis patients.
    Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
    Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ten years after publishing results from The Heart Outcomes Prevention Evaluation Study--HOPE: implications on treatment with angiotensin converting enzyme inhibitors in clinical practice].
    Pocanić D
    Lijec Vjesn; 2011; 133(1-2):69-71. PubMed ID: 21644282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ramipril: a review of its use in the prevention of cardiovascular outcomes.
    Warner GT; Perry CM
    Drugs; 2002; 62(9):1381-405. PubMed ID: 12076194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.
    Van Mieghem W; Billiouw JM; Brohet C; Dupont AG; Gazagnes MD; Heller F; Krzesinski JM; Missault L; Persu A; Piérard L; Rottiers R; Vanhooren G; Vervaet P; Herman AG
    Acta Clin Belg; 2010; 65(2):107-14. PubMed ID: 20491360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
    Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
    Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
    Mann JF; Lonn EM; Yi Q; Gerstein HC; Hoogwerf BJ; Pogue J; Bosch J; Dagenais GR; Yusuf S;
    Kidney Int; 2004 Apr; 65(4):1375-80. PubMed ID: 15086477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.
    Tu K; Mamdani MM; Jacka RM; Forde NJ; Rothwell DM; Tu JV
    CMAJ; 2003 Mar; 168(5):553-7. PubMed ID: 12615747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ
    Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summaries for patients. Trial of a drug to decrease the risk for heart disease in patients with mild kidney failure.
    Ann Intern Med; 2001 Apr; 134(8):S-96. PubMed ID: 11324633
    [No Abstract]   [Full Text] [Related]  

  • 37. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Info-Congress. The HOPE Study: Demonstration of the cardiovascular protection of ramipril, an ACE-inhibitor].
    Scheen AJ
    Rev Med Liege; 1999 Oct; 54(10):835-6. PubMed ID: 10605322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.
    Fried LF; Shlipak MG; Crump C; Bleyer AJ; Gottdiener JS; Kronmal RA; Kuller LH; Newman AB
    J Am Coll Cardiol; 2003 Apr; 41(8):1364-72. PubMed ID: 12706933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.